OLOh Haeng Lee

Oh Haeng Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oh Haeng Lee has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Accuracy of Four Intravenous Infusion Devices in a Clinical Setting: A Randomized Controlled Trial

    by Oh Haeng Lee, Young Ki Kim, Dong-Hyun Kang, Hyun Kang

    Introduction/Objective: Accurate delivery of intravenous fluids is essential for patient safety, but the flow rate accuracy of different infusion devices in clinical settings remains incompletely characterized. This study aims to compare the flow rate accuracy of four intravenous infusion devices-Terufusion TE-112, Volumed μVP7000, Auto Clamp, and Infucon-across multiple flow rates in patients undergoing elective surgery under general anesthesia. Methods: In this single-center, randomized controlled trial, 80 adult patients (ASA physical status 1–2) scheduled for elective surgery of more than 2 hours were randomized to one of four infusion device groups (n = 20 per group). Each device delivered 0.9% normal saline at set flow rates of 10, 50, 100, and 200 mL/h for 30 minutes each. Delivered volumes were calculated by gravimetric measurement using a calibrated electronic balance. Accuracy was expressed as delivered/set flow rate (%). Between-group differences were analyzed using a Linear Mixed-Effects Model (LMEM) and Wilks' lambda MANOVA. Results: LMEM revealed a significant between-group difference (F[3,313] = 5.690, P = 0.001). Infucon consistently over-delivered compared with all other devices (MANOVA: F(12,193.43) = 11.983, p < 0.001; λ = 0.230). Mean overall accuracies were: Terufusion TE-112, 96.72 ± 0.98%; Volumed μVP7000, 96.35 ± 1.34%; Auto Clamp, 100.19 ± 0.88%; and Infucon, 110.31 ± 1.88%. Infucon exceeded ±10% error at 10 mL/h (+17.25%) and 50 mL/h (+10.16%). Bland–Altman overall limits of agreement were ±1.92, ±2.62, ±1.72, and ±3.68 mL, respectively. Discussion: Three intravenous infusion devices accurately administered drugs within ±10% of the set flow rate under all test conditions. The gravity flow controller (Infucon) was consistently overdosed, reaching an average accuracy of 110.31%, particularly at low flow rates, with clinically meaningful implications for fluid and drug management. Conclusion: Three of the four tested infusion devices demonstrated clinically acceptable flow-rate accuracy across all tested conditions. The gravity-type flow regulator (Infucon) showed significant over-infusion.

  • Open Access

    Effectiveness of atorvastatin, methylene blue, and lidocaine as chemical antiadhesion agents in preventing postoperative remote adhesions: a randomized controlled experimental study in a rat model

    by Young Jin Kim, Hyun Kang, Oh Haeng Lee, Seung Eun Lee, Soon Auck Hong, Suk-Won Suh, Yoo Shin Choi

    Kim YJ, et al. Ann Surg Treat Res. 2026 Jan;110(1):56-63. https://doi.org/10.4174/astr.2026.110.1.56


  • Open Access

    Two paths, one goal–uniting regional and general anesthesia for optimal surgical care: a narrative review

    by Min Kyoung Kim, Oh Haeng Lee, Hyun Kang

    The integration of regional anesthesia (RA) with general anesthesia (GA) has become a central component of multimodal strategies to improve perioperative pain management. This approach not only enhances analgesic efficacy but also reduces opioid requirements and mitigates opioid-related adverse effects. By targeting peripheral or neuraxial nociceptive pathways, RA attenuates the surgical stress response and decreases central sensitization, complementing the systemic actions of GA. The combined application of RA and GA has shown substantial benefits across a wide range of surgical procedures, including abdominal, thoracic, orthopedic, and pediatric operations. Reported advantages include improved hemodynamic stability, enhanced pulmonary function, earlier ambulation, faster gastrointestinal recovery, and greater patient satisfaction. Moreover, recent evidence indicates a positive association between effective postoperative pain control and long-term outcomes, such as reduced incidence of persistent postsurgical pain, better functional independence, and even improved immune function and survival following cancer surgery. The development of sustained-release local anesthetic delivery systems, which provide localized and prolonged analgesia, further extends the benefits of RA-GA integration into the postoperative period. This review summarizes the mechanistic rationale, clinical applications, and future directions of RA-GA combinations in modern surgical care, with special emphasis on their role in enhanced recovery after surgery protocols.


  • Open Access

    Pain assessment using the Analgesia Nociception Index in patients undergoing sedation: a systematic review and meta-analysis

    by Min Kyoung Kim, Oh Haeng Lee, Geun Joo Choi, Hyun Kang

    Min Kyoung Kim, Oh Haeng Lee, Geun Joo Choi, and Hyun Kang. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25105


  • Open Access

    Updated sedative basics guide: everything you need to know about sedatives in clinical practice

    by Oh Haeng Lee

    Background: As interventional procedures become more common in clinical practice, sedatives are being increasingly used to enhance patient experience, overall safety, and procedural efficacy. An appropriate sedation depth, which is crucial for patient safety, is determined according to sedative dosage, procedural stimuli, and patient status. Thus, it is important that clinicians understand the continuous nature of sedation levels.Current Concepts: Although sedation offers benefits, it also carries risks. Thus, vigilant monitoring during and after a procedure is important for preventing excessive sedation depth and related complications. Combining sedatives with analgesics, including opioids, often has a synergistic effect that necessitates a dosage reduction. Interdisciplinary guidelines for moderate sedation were recently developed to address expanding procedural scopes and patient population diversity.Discussion and Conclusion: To ensure sedation safety and success in new procedures, healthcare providers should refer to relevant studies. In cases with limited evidence, sedative dosages should be determined based on their pharmacological characteristics.